When threshold was set at 6.965, the performance of plasma MYCN/NAGK ratio was 0.943, with 86.5% sensitivity and 100% specificity to discriminate amplified MYCN in NB (Fig. 1). This evidence concerns the gene NAGK and neuroblastoma.